Epigenetics Market Predicted to Garner USD 12.7 Billion By 2033, At CAGR 19.2% | Exclusive Report by Marketresearch.biz
According to Marketresearch.biz, the increase in global cancer cases propels the growth of drugs derived from epigenetic research, effectively targeting specific cancer types and reducing treatment costs worldwide. Recent research highlights epigenetics' significance in bowel cancer progression, impacting gene availability and expression without genetic code alteration.
New York, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The epigenetics market was valued at *USD 2.3 billion* in 2023 with a significant growth and is projected to reach at *USD 12.7 billion* by 2033 with a *CAGR of 19.2%.*The epigenetics market is witnessing substantial growth compelled by the surge in demand for advanced technologies and the growing pervasiveness of cancer and AIDS globally. Epigenetics, known for its use in non-oncology conditions, presents significant opportunities for market expansion.
Epigenetic pathways are straightforwardly linked to numerous health issues, comprising of cancer, cardiovascular diseases, reproductive health, and cognitive disorders. Advanced epigenetic instruments and genome sequencing are being designed to beat the limitations of traditional microarrays, by providing several benefits such as low sample concentration and lack of experimental biases.
The increasing occurrence of cancer has propelled the growth of drugs derived from epigenetic research, efficiently aiming specific cancer types and decreasing treatment costs globally. Notably, recent research highlights the importance of epigenetics in the progression of bowel cancer, enlightening its impact on gene availability and expression without changing the genetic code.
With a rise in global cancer cases, predominantly noted in recent statistics, the epigenetics market is poised for significant expansion. Advanced CRISPR-based technology augments to the momentum, permitting targeted manipulation of epigenetic identification marks for potential therapeutic applications. Government funds in healthcare research worldwide further support the market's growth, making sure the progression of high-quality standards to meet patient needs for better and more refined technologies.
*Get additional highlights on major revenue-generating segments, Request a Epigenetics Market sample report at* https://marketresearch.biz/report/epigenetics-market/request-sample/
*Key Takeaways*
· *Kits and reagents* strongly hold the product analysis segment due to *widespread* application across various* epigenetic experiments* and *procedures*.
· *NGS dominates *the technique analysis market segment due to its *potentiality* to offer comprehensive genomic data, including *epigenetic modifications* across the genome.
· *Cardiovascular diseases* lead the application market segment due to rise in occurrence of these conditions and the recognition of *epigenetic factors* in their development.
· *Pharmaceutical and biotech* companies dominates the end-user market segment due to basic research and development in *epigenetics*, often working together with *pharmaceutical companies* for translational research.
· *North America* rules the regional segment with *35%* market share due to its advanced *research infrastructure*, *substantial funding* for *biomedical research*, and leading *pharmaceutical and biotechnology* companies.
*Driving Factors*
*New Technological Innovations*
The epigenetics market is experiencing significant growth, propelled by advancements in technologies like CRISPR-based gene editing and single-cell epigenomics. These cutting-edge tools are revolutionizing the field, enabling deeper and more comprehensive studies. This technological leap is critical in fostering new discoveries in biology, biotechnology, and healthcare, significantly expanding the scope and potential of epigenetics research.
*Innovative Diagnostic Applications*
The utilization of epigenetic biomarkers for early disease detection, particularly in cancer diagnostics, marks a pivotal shift in the epigenetics market. This innovation in diagnostics is not only enhancing early disease detection but also shaping the future of personalized medicine, thereby contributing significantly to the growth of the epigenetics market.
*To understand how our report can bring a difference to your business strategy, Inquire about a brochure at* https://marketresearch.biz/report/epigenetics-market/#inquiry
*Restraining Factors*
*Huge expense of medical Instruments*
Equipment used for epigenetic analysis such as next-generation sequencing (NGS) and mass spectrometry are expensive investments that often prevent many research institutions with limited funds or in developing regions from purchasing these technologies. Due to affordability concerns, access is restricted thus restricting market expansion beyond well-funded organizations limiting democratization of epigenetic research applications.
*Have Queries? Speak to an expert or To Download/Request a Sample,* Click here.
*Report Scope*
Report Attribute Details
Market Value (2023) US$ 2.3 Billion
Market Size (2033) US$ 12.7 Billion
CAGR (from 2024 to 2033) 19.2% from 2024 to 2033
North America Region Revenue Share 35%
Historic Period 2016 to 2023
Base Year 2023
Forecast Year 2024 to 2033
*Growth Opportunities*
*Increasing Prevalence of Chronic Diseases*
Epigenetics market growth has been fuelled by an increasing global prevalence of chronic diseases like cancer, heart diseases, and diabetes, all of which contain epigenetic components. According to World Health Organization reports on chronic disease prevalence estimates; due to this significant surge, advanced diagnostic and treatment methods must be put in place as soon as possible. Epigenetic research plays an essential part in understanding disease mechanisms which opens doors for novel therapeutic approaches and expands epigenetic market size exponentially.
*Regional Analysis*
North America dominates the epigenetics market with a strong position ascribed to active research in cancer, cardiovascular diseases, and genetic disorders. Alliances among academic institutions, research organizations, and biotech industries, coupled with a well-established healthcare system, strengthen its leadership. Europe succeeds on strong research initiatives, investment, and key market players, while the Asia-Pacific region arises with growing funds, predominantly in China and Japan, likely significant market expansion driven by healthcare research, tailored medicine, and cumulative chronic diseases.
*Grow your profit margin with Marketresearch.biz - Purchase This Premium Report at* https://marketresearch.biz/purchase-report/?report_id=3529
*Segment Analysis*
By product segment, kits and reagents form the core of the epigenetics market due to their widespread application across various epigenetic experiments and procedures. The Kits segment exhibits the largest share in epigenetics, contributing significantly to overall segment growth. Instruments such as sequencers and mass spectrometers are critical tools for epigenetic analysis, while enzymes play an essential role in changing DNA and histones.
In method analysis segment, DNA methylation is a leading method in epigenetics research. It's fundamental in understanding gene expression and regulation and is implicated in various diseases. This method's dominance is attributed to its established role in epigenetics and the increasing interest in its role in cancer and other diseases. Histone modifications are also crucial in understanding chromatin structure and function.
In technique analysis market segment, NGS is the dominant technique in epigenetics due to its ability to provide comprehensive genomic data, including epigenetic modifications across the genome. PCR & qPCR are essential for quantifying epigenetic changes. Mass spectrometry is used in protein modification analysis. The scalability and decreasing cost of NGS contribute to its widespread adoption.
By application market segment, cardiovascular diseases are gaining attention due to the increasing prevalence of these conditions and the recognition of epigenetic factors in their development. Oncology is a key application area, with epigenetics providing insights into cancer development and potential treatments.
In end-user market segment, academic and research institutes are important in epigenetics market. Pharmaceutical and biotech companies are increasingly investing in epigenetic research for drug development.
*For more insights on the historical and Forecast market data from 2016 to 2033 - download a sample report at* https://marketresearch.biz/report/epigenetics-market/request-sample/
*Segments Covered in this Report*
*By Product*
· Kits and Reagents
· Instruments
· Enzymes
· Equipment & Accessories
· Software
· Service
*By Method*
· DNA Methylation
· Histone Modifications
· Other
*By Technique*
· NGS
· PCR & qPCR
· Mass Spectrometry
· Sonication
· Other
*By Application*
· Cardiovascular Diseases
· Oncology
· Metabolic Diseases
· Immunology
· Developmental Biology
· Other
*By End User*
· Academic and Research Institutes
· Pharmaceutical and Biotechnology Companies
· Contract Research Organizations
*By Geography*
· North America
· Europe
· Asia-Pacific
· Latin America
· Middle East & Africa
*Competitive Landscape Analysis*
Bio-Rad Laboratories, Inc. and Thermo Fisher Scientific Inc. are industry leaders, known for their extensive range of research tools and reagents. Diagenode, QIAGEN, and Abcam Plc. specialize in providing high-quality kits and reagents for epigenetic research, with a strong focus on innovation and user-friendly solutions. Zymo Research and Active Motif stand out for their dedicated focus on epigenetic research, offering specialized products and services that cater to niche market needs. These key players in the epigenetics market drive the industry forward through their emphasis on technological advancement, diverse product offerings, and a focus on addressing the complex needs of epigenetic research.
*Key Market Players*
· Bio-Rad Laboratories, Inc.
· Thermo Fisher Scientific Inc.
· Diagenode Inc.
· Qiagen NV
· Abcam Plc.
· New England Biolabs
· Agilent Technologies
· Zymo Research
· PerkinElmer, Inc.
· Active Motif
· Illumina Inc.
· Merck KGaA
· Roche Diagnostics
· Perkin Elmer
· Agilent Technologies, Inc.
· F. Hoffmann-La Roche Ltd
· Novartis AG
· Chroma Medicine, Inc
· Promega Corporation
· Hologic Inc.
· AsisChem Inc.
· BioVision Inc.
· PerkinElmer Inc.
*Recent Developments*
· *In September 2023*, Estée Lauder Companies Inc. shared its latest clinical research findings at the IFSCC Congress in Barcelona, Spain. a keynote address titled "Harnessing Epigenetics: from Anti-Aging to Age Reversal. This presentation highlighted the role of epigenetics in skin aging and the potential to reverse skin aging through understanding epigenetic signals.
· *In 2023*, FOXO Technologies Inc., a leader in commercializing epigenetic biomarker technology, collaborates with DataRobot to leverage the power of artificial intelligence for epigenetic biomarker research in human longevity. This collaboration aims to generate data-driven insights that promote optimal health and longevity.
· *In 2022*, Yang et al. explored the potential of targeting histone methylation to treat type 2 diabetes mellitus. Their research focused on the development of epigenetic-based therapies for T2D, including drugs that target histone methylations.
*Browse More Related Reports*
Genomics Market size in terms of revenue is estimated to be worth *US$ 48.6 billion* in 2023 and is poised to reach *US$ 186.7 billion* by 2032, growing at a *CAGR of 14.8%* from 2023 to 2032.
Laboratory Information Systems Market size is expected to be worth around *USD 4.5 Bn* by 2032 from *USD 1.8 Bn* in 2022, growing at a *CAGR of 9.6%* during the forecast period from 2023 to 2032.
Dandruff Treatment Market size is expected to be worth around *USD 15.6 Bn by 2032* from* USD 8.6 Bn in 2022*, growing at a *CAGR of 6.3%* during the forecast period from 2023 to 2032.
Plasma Fractionation Market size is expected to be worth around *USD 61.6 Bn* by 2032 from *USD 35.9 Bn* in 2022, growing at a *CAGR of 5.7%* during the forecast period from 2023 to 2032.
*About Us:*
MarketResearch.Biz (Powered by Prudour Pvt Ltd) specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicated market research report-providing firm. MarketResearch.Biz provides customization to suit any specific or unique requirement and tailor-made reports as per request. We go beyond boundaries to take analytics, analysis, study, and outlook to newer heights and broader horizons.
*Follow Us on LinkedIn:* https://www.linkedin.com/company/marketresearch-biz/
*Follow Us on Facebook:* https://www.facebook.com/marketresearch.biz
*Follow Us on Twitter:* https://twitter.com/PrudourResearch
CONTACT: Global Business Development Team – MarketResearch.biz
MarketResearch.biz (Powered By Prudour Pvt. Ltd.)
Email: inquiry@marketresearch.biz
Address: 420 Lexington Avenue, Suite 300,
New York City, NY 10170, United States
Tel: +1 347 796 4335
Website: https://marketresearch.biz/